Effecst of capecitabine (X) on quality of life (Qol) in patients (pts) with metastatic coloretal cancer (MCRC)
C. A. M. Beato Miriam Hatsue Honda Federico; B. Van Eyll; S Cabral; M Perdicaris; N. G Skare; S Lago; M. P Carvalho; G. L Moura; R. C Duarte; Annual Meeting Proccedings (40. 2004 New Orleans)
Journal of Clinical Oncology Philadelphia v. 22, n. 14S, res. 8119, 2004
Philadelphia 2004
Localização:
FM - Fac. Medicina
(BCSEP 2004 087 ) e outros locais(Acessar)
Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X)
J Segalla B. van Eyll; M Federico; M Perdicaris; S Cabral; N Skare; E saltz; G Moura; U Filho; F Franke; Annual Meeting of the American Society of Clinical Oncology 2010 Orlando) (41
Journal of Clinical Oncology Philadelphia v. 23, n. 16S , p. 751s, res. 8090, 2005
Health related quality of life (HRQoL) and demographic characteristics of long term head and neck cancer survivors submitted to concomitant chemoradiation in Brazil
D. V Santos I Snitcovsky; K. M Kiyota; G. M Leitão; M. H Federico; Annual Meeting of the American Society of Clinical Oncology (ASCO) 2006 Atlanta, GA 42
Journal of Clinical Oncology New York v. 24, n. 18S , suppl., res. 18572, jun. 2006